Engineering new bone via a minimally invasive route using human bone marrow-derived stromal cell aggregates, microceramic particles, and human platelet-rich plasma gel

Tissue Engineering - Part A

Volumn 19, Issue 3-4, 2013, Pages 340-349

  Chatterjea, Anindita ^a   Yuan, Huipin ^a   Chatterjea, Supriyo ^a   Garritsen, Henk ^b   Renard, Auke ^c   Van Blitterswijk, Clemens A ^a   De Boer, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b KLINIKUM BRAUNSCHWEIG   (Germany)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; BONE; CALCIUM PHOSPHATE; CELL CULTURE; CELL ENGINEERING; CELLS; DEFECTS; FLOWCHARTING; PLASMA (HUMAN); THERMOELECTRICITY; TISSUE;

BONE DEFECT; BONE FORMATION; CELL VIABILITY; CELL-BASED; DEFECT SITES; HUMAN BONES; IN-SITU FORMING; IN-VITRO; IN-VIVO; MESENCHYMAL STROMAL CELLS; MICRO-PARTICLES; MINIMALLY INVASIVE; MINIMALLY-INVASIVE TECHNIQUE; OPEN SURGERY; PLATELET RICH PLASMA; SCAFFOLDING MATERIALS; SINGLE-CELL SUSPENSIONS; STATISTICALLY SIGNIFICANT DIFFERENCE; STROMAL CELLS; TISSUE-ENGINEERED CONSTRUCTS;

SCAFFOLDS (BIOLOGY);

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE PROSTHESIS; CELL AGGREGATION; CELL CULTURE; CERAMICS; CYTOLOGY; GEL; HUMAN; MATERIALS TESTING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METHODOLOGY; MINIMALLY INVASIVE SURGERY; MOUSE; MULTIMODALITY CANCER THERAPY; PARTICLE SIZE; PHYSIOLOGY; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; TISSUE REGENERATION; TREATMENT OUTCOME;

ANIMALS; BONE DEVELOPMENT; BONE SUBSTITUTES; CELL AGGREGATION; CELLS, CULTURED; CERAMICS; COMBINED MODALITY THERAPY; GELS; GUIDED TISSUE REGENERATION; HUMANS; MATERIALS TESTING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; PARTICLE SIZE; PLATELET-RICH PLASMA; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TISSUE ENGINEERING; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84872109690     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0104     Document Type: Article

References (47)

1. Banwart, J.C., Asher, M.A., and Hassanein, R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evalu-ation. Spine (Phila Pa 1976) 20, 1055, 1995.
2. Dimitriou, R., et al. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 42 Suppl 2, S3, 2011.
3. Zimmermann, G., and Moghaddam, A. Allograft bone ma-trix versus synthetic bone graft substitutes. Injury 42 Suppl 2, S16, 2011.
4. Roberts, S.J., et al. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 32, 4393, 2011.
5. Meijer, G.J., et al. Cell based bone tissue engineering in jaw defects. Biomaterials 29, 3053, 2008.
6. van Gaalen, S.M., et al. Bone tissue engineering for spine fusion: an experimental study on ectopic and orthotopic implants in rats. Tissue Eng 10, 231, 2004.
7. Viateau, V., et al. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res 25, 741, 2007.
8. Vacanti, C.A., et al. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344, 1511, 2001.
9. Perka, C., et al. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fi-brin scaffolds in rabbits. Biomaterials 21, 1145, 2000.
10. Mankani, M.H., et al. Creation of new bone by the percuta-neous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14, 1949, 2008.
11. Temenoff, J.S., and Mikos, A.G. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21, 2405, 2000.
12. Xu, X.L., et al. Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering. J Biomed Mater Res B Appl Biomater 75, 289, 2005.
13. Griffith, L.G., and Naughton, G Tissue engineering\-cur-rent challenges and expanding opportunities. Science 295, 1009, 2002.
14. Park, S.H., et al. Calcium phosphate combination biomate-rials as human mesenchymal stem cell delivery vehicles for bone repair. J Biomed Mater Res B Appl Biomater 97, 235, 2011.
15. Su, C.Y., et al. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 48, 2414, 2008.
16. Su, C.Y., et al. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical appli-cations of PRF. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 56, 2009.
17. Walsh, W.R., et al. Spinal fusion using an autologous growth factor gel and a porous resorbable ceramic. Eur Spine J 13, 359, 2004.
18. Trombi, L., et al. Good manufacturing practice-grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiation. Trans-fusion 48, 2246, 2008.
19. Rosenborg, M., et al. Considerations in the corticosteroid treatment of bone cysts. J Pediatr Orthop 9, 240, 1989.
20. Jegoux, F., et al. In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant. Arch Orthop Trauma Surg 125, 153, 2005.
21. Kania, R.E., et al. Addition of fibrin sealant to ceramic pro-motes bone repair: long-term study in rabbit femoral defect model. J Biomed Mater Res 43, 38, 1998.
22. Tholpady, S.S., et al. Repair of an osseous facial critical-size defect using augmented fibrin sealant. Laryngoscope 109, 1585, 1999.
23. Isogai, N., et al. Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast Reconstr Surg 105, 953, 2000.
24. Balaguer, T., et al. Biphasic calcium phosphate microparticles for bone formation: benefits of combination with blood clot. Tissue Eng Part A 16, 3495, 2010.
25. Yamada, Y., et al. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegrad-able scaffold. J Craniomaxillofac Surg 31, 27, 2003.
26. Yamada, Y., et al. Autogenous injectable bone for regenera-tion with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10, 955, 2004.
27. Liu, Y., et al. Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plas-ma. Biomaterials 29, 3338, 2008.
28. Mouline, C.C., et al. Osteoclastic differentiation of mouse and human monocytes in a plasma clot/biphasic calcium phosphate microparticles composite. Eur Cell Mater 20, 379, 2010.
29. Ma, D., et al. Engineering injectable bone using bone marrow stromal cell aggregates. Stem Cells Dev 20, 989, 2011.
30. Frith, J.E., Thomson, B., and Genever, P.G. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16, 735, 2010.
31. Wang, W., et al. 3D spheroid culture system on micro-patterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 30, 2705, 2009.
32. Xia, Y., et al. Complex optical surfaces formed by replica molding against elastomeric masters. Science 273, 347, 1996.
33. Chu, P.J., and Shih, J.T. Arthroscopically assisted use of in-jectable bone graft substitutes for management of scaphoid nonunions. Arthroscopy 27, 31, 2011.
34. Fonoff, E.T., et al. Endoscopic approaches to the spinal cord. Acta Neurochir Suppl 108, 75, 2011.
35. Aulakh, T.S., et al. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty. Biomaterials 30, 1732, 2009.
36. Cavagna, R., Daculsi, G., and Bouler, J.M. Macroporous calcium phosphate ceramic: a prospective study of 106 cases in lumbar spinal fusion. J Long Term Eff Med Implants 9, 403, 1999.
37. De Long, W.G., Jr., et al. Bone grafts and bone graft substi-tutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 89, 649, 2007.
38. Kretlow, J.D., et al. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 21, 3368, 2009.
39. Brittberg, M., et al. Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials 18, 235, 1997.
40. Ho, W., et al. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concen-tration and clot structure. Tissue Eng 12, 1587, 2006.
41. Tischler, M. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. N Y State Dent J 68, 22, 2002.
42. Okuda, K., et al. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74, 849, 2003.
43. Janicki, P., et al. Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation. Acta Biomater 6, 3292, 2010.
44. Higashi, T., and Okamoto, H. Influence of particle size of calcium phosphate ceramics as a capping agent on the for-mation of a hard tissue barrier in amputated dental pulp. J Endod 22, 281, 1996.
45. Martino, M.M., et al. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 30, 1089, 2009.
46. Kale, S., et al. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Bio-technol 18, 954, 2000.
47. Fernandes, H., et al. Endogenous collagen influences differ-entiation of human multipotent mesenchymal stromal cells. Tissue Eng Part A 16, 1693, 2010.